硬斑病病情评估的研究进展  

The Development in the Evaluation of Morphea

作　　者：周海燕[1] 吕小岩[1] ZHOU Haiyan;LYU Xiaoyan(Department of Dermatology,West China Hospital,Sichuan University,Chengdu 610041,China)

机构地区：[1]四川大学华西医院,四川成都610041

出　　处：《中国皮肤性病学杂志》2020年第4期470-472,共3页The Chinese Journal of Dermatovenereology

摘　　要：硬斑病(morphea)是一种引起皮肤和/或深部组织硬化性改变的特发性炎症性皮肤疾病。对硬斑病病情做出准确评估才能制定合理的治疗措施。目前,已经发展出较丰富的评估方法,本文简要综述当前硬斑病的临床评估、仪器评估(例如超声、硬度计、弹性测量仪、肌电图、核磁共振成像)和具有潜在临床应用前景的血清生物标志物。Morphea is an idiopathic inflammatory skin diseases with cutaneous and/or subcutaneous sclerosis.Accurate assessment of this condition can make reasonable treatment.In recent years,a variety of evaluation methods have been developed.This paper briefly reviewed the current clinical assessment,instrumental evaluation(e.g.,ultrasound,durometer,cutometer,electromyography,MRI) and new serum biomarkers with potential clinical applications.

关 键 词：硬斑病 病情评估 

分 类 号：R593.25[医药卫生—内科学]